Test tubes labelled"COVID-19 Test Positive" are seen in front of displayed words"OMICRON SARS-COV-2" in this illustration. [File image]
They are also testing a fourth dose of the current vaccine against a fourth dose of the Omicron-based vaccine in people who received their third dose of the Pfizer/BioNTech vaccine three to six months earlier. The companies plan to study the safety and tolerability of the shots in the more than 1,400 people who will be enrolled in the trial.
Pfizer has said that a two-dose regimen of the original vaccine may not be sufficient to protect against infection from the Omicron variant, and that protection against hospitalizations and deaths may be waning. Still, the U.S. Centers for Disease Control and Prevention says a third dose of an mRNA vaccine like the Pfizer/BioNTech vaccine has provided 90% protection against hospitalization due to COVID-19.
BioNTech Chief Executive Ugur Sahin said that regulators would not likely require testing of an Omicron-based vaccine on humans because it and Pfizer had already created versions of their established vaccine to target the earlier Alpha and Delta variants, with clinical trials continuing.
Usa and Europe are the target markets here. This variant is showing them flames there.
SA will be a dumping site as usual.....seen as a gate to Africa. This is helped by the allegedly weak president.
As a mother of two kids I have battled alot with my financial state to the point of begging from friends just to survive,until I started Bitcoin trading with the help of _AMBREYMARCUS1 I made a successful withdrawal of R 200,000 with the help of _AMBREYMARCUS1 .